Obstetrics and Gynecology International / 2012 / Article / Tab 2

Clinical Study

Indications and Outcomes of Uterine Artery Embolization in Patients with Uterine Leiomyomas

Table 2

General indications and contraindications of uterine artery embolization in patients with uterine leiomyomas.

 (1) Hypermenorrhea and/or dysmenorrhea
 (2) Absence of a malignant tumor in the uterus and lesion in the adnexa
 (3) Absence of a pelvic inflammatory disease
 (4) No childbearing
 (1) No symptoms
 (2) Large leiomyoma (more than 10 cm in diameter) and/or multiple leiomyomas
 (3) Coexistence of a malignant tumor in the uterus or a lesion in the adnexa
 (4) Active pelvic inflammatory disease
 (5) Hormone therapy (required for 8–12 weeks after the therapy)
 (6) During pregnancy
 (7) Menopause
 (8) Hope of childbearing
 (9) Allergy to iodine

Department of Radiology, National Defense Medical College Hospital, Japan.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.